ea0046p8 | (1) | UKINETS2016
Modlin Irvin M
, Frilling Andrea
, Salem Ronald R
, Alaimo Daniele
, Drymousis Panagiotis
, Wasan Harpreet S
, Callahan Stephen
, Faiz Omar
, Weng Lei
, Teixeira Nancy
, Bodei Lisa
, Drozdov Ignat
, Kidd Mark
Background: Surgery is the only curative treatment for gastroenteropancreatic neuroendocrine tumors (GEP-NETs), but the prediction of residual disease/recurrence is limited in the absence of optimal biomarkers. We examined whether a blood-based multianalyte neuroendocrine gene transcript assay (NETest) would define tumor cytoreduction and therapeutic efficacy.Methods: The NETest is a polymerase chain reaction–based analysis of 51 genes. Disease acti...